SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Adient plc – ‘8-K’ for 8/5/22 – ‘EX-99.1’

On:  Friday, 8/5/22, at 6:54am ET   ·   For:  8/5/22   ·   Accession #:  1670541-22-74   ·   File #:  1-37757

Previous ‘8-K’:  ‘8-K’ on / for 6/15/22   ·   Next:  ‘8-K’ on 9/23/22 for 9/16/22   ·   Latest:  ‘8-K’ on 4/22/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/05/22  Adient plc                        8-K:2,9     8/05/22   11:4.3M

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     33K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    526K 
 6: R1          Cover                                               HTML     47K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 7: XML         XBRL Instance -- adnt-20220805_htm                   XML     22K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- adnt-20220805_lab                     XML     69K 
 5: EX-101.PRE  XBRL Presentations -- adnt-20220805_pre              XML     34K 
 3: EX-101.SCH  XBRL Schema -- adnt-20220805                         XSD     10K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    17K 
11: ZIP         XBRL Zipped Folder -- 0001670541-22-000074-xbrl      Zip     41K 


‘EX-99.1’   —   Miscellaneous Exhibit


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  
Exhibit 99.1
q3fy22earningsinfographic_c.jpg




q3fy22earningsinfographic_.jpg




q3fy22earningsinfographic_a.jpg



q3fy22earningsinfographic_b.jpg


Appendix
Page 1

Adient plc
Condensed Consolidated Statements of Income
(Unaudited)
Three Months Ended
June 30,
(in millions, except per share data)20222021
Net sales$3,485 $3,242 
Cost of sales3,312 3,092 
Gross profit173 150 
Selling, general and administrative expenses142 136 
Restructuring and impairment costs12 
Equity income (loss)16 38 
Earnings (loss) before interest and income taxes35 44 
Net financing charges39 87 
Other pension expense (income)(4)(4)
Income (loss) before income taxes— (39)
Income tax provision (benefit)20 10 
Net income (loss)(20)(49)
Income attributable to noncontrolling interests10 22 
Net income (loss) attributable to Adient$(30)$(71)
Diluted earnings (loss) per share$(0.32)$(0.75)
Shares outstanding at period end94.8 94.2 
Diluted weighted average shares94.8 94.2 



Appendix
Page 2

Adient plc
Condensed Consolidated Statements of Financial Position
(Unaudited)

June 30,September 30,
(in millions)20222021
Assets
Cash and cash equivalents$892 $1,521 
Accounts receivable - net
1,761 1,426 
Inventories953 976 
Assets held for sale— 49 
Other current assets456 1,114 
Current assets4,062 5,086 
Property, plant and equipment - net1,443 1,607 
Goodwill2,122 2,212 
Other intangible assets - net504 555 
Investments in partially-owned affiliates348 335 
Assets held for sale25 
Other noncurrent assets829 958 
Total assets$9,315 $10,778 
Liabilities and Shareholders' Equity
Short-term debt$20 $184 
Accounts payable and accrued expenses2,697 2,519 
Liabilities held for sale— 16 
Other current liabilities670 792 
Current liabilities3,387 3,511 
Long-term debt2,707 3,512 
Other noncurrent liabilities723 797 
Redeemable noncontrolling interests45 240 
Shareholders' equity attributable to Adient2,123 2,376 
Noncontrolling interests330 342 
Total liabilities and shareholders' equity$9,315 $10,778 




Appendix
Page 3

Adient plc
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Three Months Ended
June 30,
(in millions)20222021
Operating Activities
Net income (loss) attributable to Adient$(30)$(71)
Income attributable to noncontrolling interests10 22 
Net income (loss)(20)(49)
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities:
Depreciation72 71 
Amortization of intangibles14 10 
Pension and postretirement benefit expense (benefit)(3)(1)
Pension and postretirement contributions, net(7)(6)
Equity in earnings of partially-owned affiliates, net of dividends received10 245 
Deferred income taxes13 (2)
Non-cash restructuring and impairment charges
Equity-based compensation10 
Other— 
Changes in assets and liabilities:
Receivables(83)315 
Inventories(87)
Other assets14 
Restructuring reserves(11)(23)
Accounts payable and accrued liabilities37 (277)
Accrued income taxes(22)(7)
Cash provided (used) by operating activities23 222 
Investing Activities
Capital expenditures(53)(60)
Sale of property, plant and equipment11 
Business acquisitions(13)(271)
Proceeds from business divestitures— 53 
Settlement of an affiliate loan— 15 
Cash provided (used) by investing activities(60)(252)
Financing Activities
Increase (decrease) in short-term debt— 30 
Increase (decrease) in long-term debt— 214 
Repayment of long-term debt(144)(185)
Debt financing costs— (7)
Dividends paid to noncontrolling interests(3)(7)
Other— (1)
Cash provided (used) by financing activities(147)44 
Effect of exchange rate changes on cash and cash equivalents(42)— 
Increase (decrease) in cash and cash equivalents, including cash classified within current assets held for sale(226)14 
Less: Change in cash classified within current assets held for sale— 
Increase (decrease) in cash and cash equivalents$(226)$16 


Appendix
Page 4

Footnotes
1. Segment Results

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, qualified restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

Financial information relating to Adient's reportable segments is as follows:

Three Months Ended
June 30,
(in millions)20222021
Net Sales
Americas$1,673 $1,440 
EMEA1,215 1,328 
Asia627 516 
Eliminations(30)(42)
Total net sales$3,485 $3,242 


Three Months Ended
June 30,
(in millions)20222021
Adjusted EBITDA
Americas$70 $23 
EMEA31 22 
Asia64 92 
Corporate-related costs (1)
(22)(19)
Restructuring and impairment costs (2)
(12)(8)
Purchase accounting amortization (3)
(14)(11)
Restructuring related charges (4)
(1)— 
Stock based compensation(7)(10)
Depreciation(72)(71)
Other items (5)
(2)26 
Earnings (loss) before interest and income taxes35 44 
Net financing charges(39)(87)
Other pension income (expense)
Income (loss) before income taxes$— $(39)

Refer to the Footnote Addendum for footnote explanations.



Appendix
Page 5


2. Earnings Per Share

The following table reconciles the numerators and denominators used to calculate basic and diluted earnings (loss) per share:

Three Months Ended
June 30,
(in millions, except per share data)20222021
Income available to shareholders
Net income (loss) attributable to Adient$(30)$(71)
Weighted average shares outstanding
Basic weighted average shares outstanding94.8 94.2 
Effect of dilutive securities:
Stock options, unvested restricted stock and unvested performance share awards— — 
Diluted weighted average shares outstanding94.8 94.2 

Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted earnings per share, which for the three months ended June 30, 2022 and 2021 is a result of being in a loss position.



Appendix
Page 6

3. Non-GAAP Measures

Adjusted EBIT, Adjusted EBIT margin, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted net income attributable to Adient, Adjusted effective tax rate, Adjusted earnings per share, Adjusted equity income, Adjusted interest expense, Free cash flow and Net debt as well as other measures presented on an adjusted basis are not recognized terms under U.S. GAAP and do not purport to be alternatives to the most comparable U.S. GAAP amounts. Since all companies do not use identical calculations, our definition and presentation of these measures may not be comparable to similarly titled measures reported by other companies. Management uses the identified non-GAAP measures to evaluate the operating performance of the Company and its business segments and to forecast future periods. Management believes these non-GAAP measures assist investors and other interested parties in evaluating Adient's on-going operations and provide important supplemental information to management and investors regarding financial and business trends relating to Adient's financial condition and results of operations. Investors should not consider these non-GAAP measures as alternatives to the related GAAP measures. Reconciliations of non-GAAP measures to their closest U.S. GAAP equivalent are presented below. Reconciliations of non-GAAP measures related to guidance for any future period have not been provided due to the unreasonable efforts it would take to provide such reconciliations.

Adjusted EBIT is defined as income before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales.
Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and stock based compensation. Certain corporate-related costs are not allocated to the business segments in determining Adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales. Adjusted EBITDA excluding adjusted equity income, each as defined herein, is also presented.
Adjusted net income attributable to Adient is defined as net income attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, expenses associated with becoming an independent company, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits.
Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes.
Adjusted earnings per share is defined as Adjusted net income attributable to Adient divided by diluted weighted average shares.
Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or one-time items impacting equity income.
Adjusted interest expense is defined as net financing charges excluding unusual or one-time items impacting interest expense.
Free cash flow is defined as cash provided by operating activities less capital expenditures.
Net debt is calculated as gross debt (short-term and long-term) less cash and cash equivalents.

Adient is also making pro forma adjustments to fiscal 2021 financial information to reflect the impacts of certain transactions (collectively, “portfolio actions”) as described below. Adient believes these pro forma adjustments provide helpful comparisons between the current year and prior year results by adjusting the prior year to be on a consistent basis with the current year.

"Americas footprint actions" and "EMEA footprint actions" refer to miscellaneous closures / roll off of business.
"EMEA deconsolidation" refers to sale of a metals business in Turkey effective October 1, 2021 to a nonconsolidated JV in which Adient retains a noncontrolling interest.
"China strategic transaction" refers to the disposition of the YFAS JV and consolidation of CQADNT and LFADNT, all of which were effective on September 30, 2021.
"China footprint actions" refers to divestitures of smaller, non-core businesses (i.e., remaining fabrics business and Futuris entity).


Appendix
Page 7

Summarized Income Statement Information
(Refer to the Footnote Addendum for footnote explanations and details
of reconciling items between GAAP results and Adjusted results)

Three Months Ended June 30,
20222021
(in millions, except per share data)GAAP ResultsAdj.Adjusted ResultsGAAP ResultsAdj.Adjusted Results
Net sales$3,485 $— $3,485 $3,242 $— $3,242 
Cost of sales (6)
3,312 (2)3,310 3,092 28 3,120 
Gross profit173 175 150 (28)122 
Selling, general and administrative expenses (7)
142 (15)127 136 (12)124 
Restructuring and impairment costs (2)
12 (12)— (8)— 
Equity income (loss) (8)
16 — 16 38 39 
Earnings (loss) before interest and income taxes (EBIT)35 29 64 44 (7)37 
Memo accounts:
Depreciation72 71 
Equity based compensation10 
Adjusted EBITDA$143 $118 
Net financing charges (9)
39 (2)37 87 (38)49 
Other pension expense (income) (12)
(4)(1)(4)(3)
Income (loss) before income taxes— 28 28 (39)30 (9)
Income tax provision (benefit) (10)
20 (11)10 17 
Net income (loss) attributable to Adient(30)38 (71)21 (50)
Diluted earnings (loss) per share(0.32)0.40 0.08 (0.75)0.22 (0.53)
Diluted weighted average shares94.8 0.9 95.7 94.2 — 94.2 



Appendix
Page 8

Segment Performance:
Three months ended June 30, 2022
AmericasEMEAAsiaCorporate/EliminationsConsolidated
Net sales$1,673 $1,215 $627 $(30)$3,485 
Adjusted EBITDA$70 $31 $64 $(22)$143 
Adjusted EBITDA margin4.2 %2.6 %10.2 %N/A4.1 %
Three months ended June 30, 2021
AmericasEMEAAsiaCorporate/EliminationsConsolidated
Net sales$1,440 $1,328 $516 $(42)$3,242 
Adjusted EBITDA$23 $22 $92 $(19)$118 
Adjusted EBITDA margin1.6 %1.7 %17.8 %N/A3.6 %

The following table presents adjusted EBITDA excluding adjusted equity income:

Three Months Ended
June 30,
(in millions)20222021
Adjusted EBITDA$143 $118 
Adjusted Equity Income16 39 
Adjusted EBITDA Excluding Adjusted Equity Income$127 $79 
% of Sales3.6 %2.4 %

The following table reconciles income (loss) before income taxes to adjusted income before income taxes and presents the related effective tax rate and adjusted effective tax rate:

Three months ended June 30,
20222021
(in millions, except effective tax rate)Income (loss) before income taxesTax impactEffective tax rateIncome (loss) before income taxesTax impactEffective tax rate
As reported$— $20 nm$(39)$10 (25.6)%
Adjustments (10)
28 (11)(39.3)%30 23.3%
As adjusted$28 $32.1%$(9)$17 nm




Appendix
Page 9

The following table reconciles net income (loss) attributable to Adient to adjusted net income (loss) attributable to Adient:

Three Months Ended
June 30,
(in millions)20222021
Net income (loss) attributable to Adient(30)(71)
Restructuring and impairment costs
12 
Purchase accounting amortization
14 11 
Restructuring related charges
— 
Pension mark-to-market and curtailment/settlement (gain)/loss (12)
(3)(1)
Write off of deferred financing costs upon repurchase of debt (9)
— 10 
Derivative loss on Yanfeng transaction (9)
— 24 
Foreign exchange loss on intercompany loan in Russia (9)
— 
Premium paid on repurchase of debt (9)
— 
Other items (5)
(26)
Impact of adjustments on noncontrolling interests (11)
(1)(2)
Tax impact of above adjustments and other tax items (10)
11 (7)
Adjusted net income (loss) attributable to Adient$$(50)

Refer to the Footnote Addendum for footnote explanations

The following table reconciles diluted earnings (loss) per share as reported to adjusted diluted earnings (loss) per share.

Three Months Ended
June 30,
20222021
Diluted earnings (loss) per share as reported$(0.32)$(0.75)
Restructuring and impairment costs0.13 0.08 
Purchase accounting amortization0.15 0.12 
Restructuring related charges0.01 — 
Pension mark-to-market and curtailment/settlement (gain)/loss (12)
(0.03)(0.01)
Write off of deferred financing costs upon repurchase of debt (9)
— 0.11 
Derivative loss on Yanfeng transaction (9)
— 0.25 
Foreign exchange loss on intercompany loan in Russia (9)
0.02 — 
Premium paid on repurchase of debt (9)
— 0.04 
Other items (5)
0.02 (0.28)
Impact of adjustments on noncontrolling interests (11)
(0.01)(0.02)
Tax impact of above adjustments and other tax items (10)
0.11 (0.07)
Adjusted diluted earnings (loss) per share$0.08 $(0.53)




Appendix
Page 10


The following table presents calculations of net debt:

June 30,September 30,
(in millions)20222021
Cash and cash equivalents$892 $1,521 
Total short-term and long-term debt2,727 3,696 
Net debt$1,835 $2,175 

The following table reconciles cash from operating activities to free cash flow:

Three Months Ended
June 30,
Nine Months Ended
June 30,
(in millions)2022202120222021
Cash provided (used) by operating activities$23 $222 $38 $362 
Capital expenditures(53)(60)(170)(186)
Free cash flow$(30)$162 $(132)$176 


The following table reconciles adjusted EBITDA excluding adjusted equity income to free cash flow:

FY2022FY2021
(in millions)Q3YTDQ3YTD
Adjusted EBITDA excluding adjusted equity income$127 $381 $79 $613 
(+) Dividend26 27 283 292 
(-) Restructuring (cash)(11)(49)(27)(127)
(+/-) Net customer tooling(15)(36)10 10 
(+/-) Trade working capital (Net AR/AP + Inventory)(57)(6)(60)37 
(+/-) Accrued compensation(45)27 35 
(-) Interest paid(23)(134)(48)(184)
(+/-) Tax refund/taxes paid(25)(63)(20)(52)
(+/-) Non-income related taxes (VAT)(20)33 (73)
(+/-) Commercial settlements(22)(66)(8)(87)
(+/-) Capitalized engineering31 33 (2)11 
(+/-) Prepaids15 (8)(1)(31)
(+/-) Other(5)(29)(16)(82)
Operating cash flow23 38 222 362 
Capital expenditures(53)(170)(60)(186)
Free cash flow$(30)$(132)$162 $176 



Appendix
Page 11

Pro Forma Fiscal Year 2021 Reconciliations:

Net salesQ1Q2Q3Q4FY2021
Americas - as reported:1,737 1,644 1,440 1,343 6,164 
Americas footprint actions(20)— — (1)(21)
Americas - pro forma1,717 1,644 1,440 1,342 6,143 
EMEA - as reported:1,604 1,636 1,328 996 5,564 
EMEA JV deconsolidation(25)(28)(11)(35)(99)
EMEA footprint actions(18)(7)(6)(30)
EMEA - pro forma1,561 1,601 1,311 962 5,435 
Asia - as reported:554 588 516 465 2,123 
China strategic transactions234 199 231 227 891 
China footprint actions(44)(33)(31)(13)(121)
Asia - pro forma744 754 716 679 2,893 
Elimination/corporate:(47)(49)(42)(33)(171)
Total Adient - as reported3,848 3,819 3,242 2,771 13,680 
Total Adient - pro forma3,975 3,950 3,425 2,950 14,300 


Adjusted EBITDAQ1Q2Q3Q4FY2021
Americas - as reported:132 64 23 13 232 
Americas footprint actions(5)— (1)(5)
Americas - pro forma127 65 23 12 227 
EMEA - as reported:114 141 22 — 277 
EMEA JV deconsolidation(4)(5)— (8)(17)
EMEA footprint actions(6)(2)(1)(1)(10)
EMEA - pro forma104 134 21 (9)250 
Asia - as reported:151 121 92 122 486 
China strategic transactions(31)(2)10 (38)(61)
China footprint actions(7)(5)(2)— (14)
Asia - pro forma113 114 100 84 411 
Elimination/corporate:(19)(23)(19)(17)(78)
Total Adient - as reported378 303 118 118 917 
Total Adient - pro forma325 290 125 70 810 





Appendix
Page 12

Footnote Addendum

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects qualified restructuring charges for costs that are directly attributable to restructuring activities and meet the definition of restructuring under ASC 420 along with one-time asset impairment charges, as follows:

Three Months Ended
June 30,
(in millions)20222021
Restructuring charges$(13)$(8)
Held for sale asset adjustments— 
$(12)$(8)

(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.

(4) Reflects non-qualified restructuring charges for costs that are directly attributable to restructuring activities, but do not meet the definition of restructuring under ASC 420 including restructuring costs at partially owned affiliates recorded within equity income.

(5) Other items include:

Three Months Ended
June 30,
(in millions)20222021
Transaction costs$(2)$(2)
Brazil indirect tax recoveries28 
Disposal of non-core assets(1)— 
$(2)$26 

(6) The adjustments to cost of sales include:

Three Months Ended
June 30,
(in millions)20222021
Restructuring related charges$(1)$— 
Brazil indirect tax recoveries28 
Purchase accounting amortization(1)— 
Disposal of non-core assets(1)— 
$(2)$28 


Appendix
Page 13


(7) The adjustments to selling, general and administrative costs include:

Three Months Ended
June 30,
(in millions)20222021
Purchase accounting amortization$(13)$(10)
Transaction costs(2)(2)
$(15)$(12)

(8) The adjustments to equity income include:

Three Months Ended
June 30,
(in millions)20222021
Purchase accounting amortization— 
$— $

(9) The adjustments to net financing charges to calculate adjusted interest expense include:

Three Months Ended
June 30,
(in millions)20222021
Derivative loss on Yanfeng transaction$— $(24)
Premium paid on repurchase of debt— (4)
Write off of deferred financing costs upon repurchase of debt— (10)
Foreign exchange loss on intercompany loan in Russia(2)— 
$(2)$(38)

(10) The adjustments to income tax provision (benefit) include:

Three Months Ended
June 30,
(in millions)20222021
Benefits associated with restructuring and impairment charges$— $(2)
Brazil indirect tax recoveries— 
Withholding tax adjustments
— (11)
Valuation allowances12 — 
Other reconciling items(1)(3)
$11 $(7)

(11) Reflects the impact of adjustments, primarily purchase accounting amortization on noncontrolling interests.

(12) During the three months ended June 30, 2022, Adient remeasured pension plans in the Americas and recorded a mark-to-market gain of $4 million and a curtailment loss of $1 million. During the three months ended June 30, 2021, Adient remeasured a pension plan in the Americas and recorded a mark-to-market gain of $1 million.


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:8/5/22
6/30/22
10/1/214
9/30/2110-K,  8-K
6/30/2110-Q,  8-K
 List all Filings 
Top
Filing Submission 0001670541-22-000074   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 9:46:49.1pm ET